LKB1 and cancer: The dual role of metabolic regulation

Biomed Pharmacother. 2020 Dec:132:110872. doi: 10.1016/j.biopha.2020.110872. Epub 2020 Oct 14.

Abstract

Liver kinase B1 (LKB1) is an essential serine/threonine kinase frequently associated with Peutz-Jeghers syndrome (PJS). In this review, we provide an overview of the role of LKB1 in conferring protection to cancer cells against metabolic stress and promoting cancer cell survival and invasion. This carcinogenic effect contradicts the previous conclusion that LKB1 is a tumor suppressor gene. Here we try to explain the contradictory effect of LKB1 on cancer from a metabolic perspective. Upon deletion of LKB1, cancer cells experience increased energy as well as oxidative stress, thereby causing genomic instability. Meanwhile, mutated LKB1 cooperates with other metabolic regulatory genes to promote metabolic reprogramming that subsequently facilitates adaptation to strong metabolic stress, resulting in development of a more aggressive malignant phenotype. We aim to specifically discuss the contradictory role of LKB1 in cancer by reviewing the mechanism of LKB1 with an emphasis on metabolic stress and metabolic reprogramming.

Keywords: Carcinogenesis; Genomic instability; Liver kinase B1; Metabolic reprogramming; Metabolic stress; Subcellular localization.

Publication types

  • Review

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Animals
  • Cellular Reprogramming
  • Energy Metabolism*
  • Gene Expression Regulation, Neoplastic
  • Genomic Instability
  • Humans
  • Neoplasms / enzymology*
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Oxidative Stress
  • Phenotype
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Signal Transduction

Substances

  • Protein Serine-Threonine Kinases
  • STK11 protein, human
  • AMP-Activated Protein Kinase Kinases